Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0000950170-23-012922
Filing Date
2023-04-14
Accepted
2023-04-14 16:52:55
Documents
8
Period of Report
2023-06-13

Document Format Files

Seq Description Document Type Size
1 PRE 14A aclx_2022_pre_14a.htm PRE 14A 957535
2 GRAPHIC img130252850_0.jpg GRAPHIC 17765
3 GRAPHIC img130252850_1.jpg GRAPHIC 5018
4 GRAPHIC img130252850_2.jpg GRAPHIC 5018
5 GRAPHIC img130252850_3.jpg GRAPHIC 17765
6 GRAPHIC img130252850_4.jpg GRAPHIC 79034
7 GRAPHIC img130252850_5.jpg GRAPHIC 50177
8 GRAPHIC img130252850_6.jpg GRAPHIC 5018
  Complete submission text file 0000950170-23-012922.txt   1207185
Mailing Address 25 WEST WATKINS MILL ROAD SUITE A GAITHERSBURG MD 20878
Business Address 25 WEST WATKINS MILL ROAD SUITE A GAITHERSBURG MD 20878 240-723-6641
Arcellx, Inc. (Filer) CIK: 0001786205 (see all company filings)

EIN.: 472855917 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-41259 | Film No.: 23821833
SIC: 2836 Biological Products, (No Diagnostic Substances)